Anxiety and Hormones: Why Women Are Hit Twice as Hard (And What Helps)

Ashwagandha KSM-66 at 300mg has among the strongest clinical evidence of any adaptogen for anxiety reduction. A 2025 RCT (PMID 40746175) showed cortisol reduction of 1.16 mcg/dL versus placebo, alongside significant reductions in standardized anxiety scores. The mechanism: withanolides (ashwagandha's active compounds) modulate the HPA axis — reducing cortisol output under stress while also influencing GABA-A receptor sensitivity in ways that appear to lower baseline anxiety tone.

Ashwagandha is not a sedative. It doesn't flatten mood or cause drowsiness. The correct framing is adaptogenic — it helps the stress response system find a more calibrated set point rather than eliminating reactivity. This makes it appropriate for daytime use in a way that benzodiazepines, for example, are not.

For women with hormonally-driven anxiety specifically: the HPA-HPG overlap means that lowering cortisol load can have downstream effects on hormone balance. This is a real two-way street — and part of why ashwagandha often improves not just anxiety but sleep, energy, and cycle regularity with consistent use.

L-theanine at 200mg — derived from green tea — has a specific and well-characterized effect: it increases alpha brainwave activity, producing a state of relaxed alertness without drowsiness. Alpha waves are associated with wakeful calm — the brain state of someone who is relaxed but fully present. L-theanine doesn't sedate; it shifts the brain from beta-dominated (alert, somewhat tense) to alpha-rich (calm, focused).

This makes L-theanine useful in a way that's different from supplements that work through GABA sedation. You can take it during the day, before a stressful meeting, or as part of an evening wind-down without impairing function. RCTs show significant reduction in situational anxiety and improvements in attention quality.

Magnesium glycinate at 300mg is a GABA cofactor — it's needed for GABA synthesis and receptor function. Magnesium deficiency is remarkably common in people with anxiety, and the symptoms of deficiency (muscle tension, difficulty sleeping, nervous restlessness) overlap so closely with anxiety that the two are often inseparable. Addressing magnesium deficiency is foundational.

Saffron extract at 30mg carries dual evidence — both for mood and anxiolytic effects in the same RCTs. The University of Reading 2022 RCT (n=478) on vitamin B6 found that supplementation significantly reduced self-reported anxiety and depression compared to placebo. B6 as P5P (pyridoxal-5-phosphate, the active form) is preferred because it bypasses the conversion step that's impaired in some people.

The B6 mechanism is directly relevant here: pyridoxal-5-phosphate is a cofactor in the synthesis of both GABA and serotonin — the two neurotransmitters most directly involved in anxiety regulation. Inadequate B6 means inadequate neurotransmitter production regardless of dietary precursor availability.

Note on B6 dosing: the Reading study used higher doses (100mg+) than the 50mg P5P in this profile. The Selene dose is chosen for safety and daily use — higher doses over very long periods have been associated with peripheral neuropathy in case reports, though this is exceedingly rare at doses far above this. At 50mg P5P daily, the benefit-to-risk ratio is favorable.

The anxiety pattern for many women is predictable once you see it: baseline anxiety rises in the luteal phase, peaks in the 3–5 days premenstrual, then often drops sharply with the onset of flow. This is the allopregnanolone pattern — the same progesterone metabolite relevant to OCD also functions as an endogenous anxiolytic, and when it drops in late luteal, anxiety rises.

Selene's cycle-aware approach means the stack can be weighted toward the luteal phase for women with a clear premenstrual anxiety pattern — higher-dose ashwagandha or L-theanine during the window where anxiety peaks, lighter support in the follicular phase.

Longer-term, consistent supplementation with the full stack appears to raise the floor — reducing baseline anxiety enough that the late-luteal spikes are less dramatic. This is a realistic goal with 2–3 months of consistent use, and it's more achievable than trying to manage the late-luteal spike acutely once it's already underway.